StonvexLoading…
StonvexStonvexStonvexCore line items from PBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-03-31 | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $1.09B | $1.14B | $1.13B | $1.13B |
Operating Income | $309.41M | $336.77M | $342.43M | $-22.41M |
Net Income | $190.30M | $214.60M | $209.34M | $-82.31M |
EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 |
Total Assets | $3.49B | $3.40B | $3.32B | $3.35B |
Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B |
Cash & Equivalents | $63.87M | $97.88M | $46.47M | $58.49M |
Free Cash Flow OCF − CapEx | $246.45M | $243.29M | $239.38M | $221.93M |
Shares Outstanding | 48.72M | 50.08M | 50.18M | 49.89M |